Germline genomic testing is increasingly used in research to identify genetic causes of disease, including cancer. However, there is evidence that individuals who are notified of clinically actionable research findings have difficulty making informed decisions regarding uptake of genetic counseling for these findings. This study aimed to produce and pilot test a decision aid to assist participants in genomic research studies who are notified of clinically actionable research findings to make informed choices regarding uptake of genetic counseling. Development was guided by published literature, the International Patient Decision Aid Standards, and the expertise of a steering committee of clinicians, researchers, and consumers. Decision aid acceptability was assessed by self-report questionnaire. All 19 participants stated that the decision aid was easy to read, clearly presented, increased their understanding of the implications of taking up research findings, and would be helpful in decision-making. While low to moderate levels of distress/worry were reported after reading the booklet, a majority of participants also reported feeling reassured. All participants would recommend the booklet to others considering uptake of clinically actionable research findings. Results indicate the decision aid is acceptable to the target audience, with potential as a useful decision support tool for genomic research participants.
Introduction
The implementation of genomic technologies increases access to testing and broadens our understanding of hereditary cancer. This has led to increasing numbers of research participants receiving clinically actionable information as a result of their research participation. Returning clinically actionable research findings to research participants not only enables researchers and clinicians to directly improve the health outcomes of research participants, but is also consistent with the reported preferences of research participants, who wish to be informed of such findings (Bollinger et al. 2012; Young et al. 2013 ). This in turn has presented a growing challenge in terms of variant interpretation and clinical management, for researchers, clinicians, and patients, particularly where the results and family history may not be concordant.
In the Australian setting, individuals recruited to genetic research studies on the basis of a personal or family history of cancer are asked to indicate at enrolment whether or not they wish to be notified of clinically actionable research findings. These studies recruit both index cases and their relatives, with recruitment of relatives facilitated by the index case participant. To date, Australian studies investigating heritable cancer risk have employed genomic technologies in the form of panel testing to identify pathogenic germline mutations in cancer susceptibility genes ; Thorne et al. 2011) . Participants from families where a clinically actionable pathogenic variant is identified in the index case are notified of the availability of research findings by letter, if they opted to receive results at study enrolment. This notification letter informs the participant that a Bgenetic change^important for their health and the health of their relatives has been identified in their family (an example letter is provided in supplementary material). The letter does not provide individual results, or information about specific cancer risks, but strongly recommends that participants contact a familial cancer clinic to discuss the research findings further. At the time of genetic counseling, index cases can opt to have confirmatory clinical genetic testing and relatives, whose mutation status is unknown, can opt to have predictive genetic testing to clarify their status.
Despite the reported preference for such notification, actual uptake of genetic counseling to receive research findings has been relatively low, with 36% (43/119) to 64% (55/94) of notified Australian research participants actually attending genetic counseling to receive their results (Kasparian et al. 2009; Keogh et al. 2004) . Research participants report a range of barriers to uptake of research findings, including financial, logistical, and organizational barriers to accessing genetic services, the timing of the notification, and concerns regarding the emotional or family impact of the information (Crook et al. 2015; Kasparian et al. 2009; McBride et al. 2016; Wakefield et al. 2011a) . Some also misinterpret the notification letter, perceiving the genetic information as not personally relevant, despite being at increased risk (Crook et al. 2015; McBride et al. 2016) . These barriers are also reflected for uptake of clinical and research genetic counseling internationally (Willis et al. 2017) . Attempts have been made to increase uptake of research findings, through a system whereby research participants who do not return a reply slip to acknowledge receipt of their results are actively followed up by phone by a genetic counselor (Wakefield et al. 2013 ). However, this method has shown no significant increase in uptake of genetic testing compared to usual care.
This low uptake of genetic services among research participants and in general must also be considered in the context of low community awareness of genetic counseling and testing in Australia and elsewhere (Mai et al. 2014; Maio et al. 2013; Molster et al. 2009 ), as well as low awareness among nongenetic health professionals (Delikurt et al. 2015) . There is also evidence of negative psychosocial outcomes among those who are referred to genetic counseling without discussion of the referral with the referring health care provider and lower decisional satisfaction among those who do not attend genetic counseling (Halbert et al. 2012; Metcalfe et al. 2007) . Such findings raise the question of whether individuals considering uptake of clinically actionable research findings have adequate information or support to make an informed decision regarding taking up such findings.
Decision aids are decision support interventions designed to facilitate informed decision-making by providing good quality, balanced information and encouraging individuals to consider their own personal values in the decision-making process. Decision aids are a well-established mode of providing decision support in health care and have been shown to improve knowledge of options and risk perception accuracy, reduce decisional conflict, increase active engagement with health care decisions, and increase decision-making that is consistent with personal values (Stacey et al. 2017) . As a decision support tool, decision aids are best applied to preference-sensitive decisions, where the risks and benefits must be carefully considered and the individual's autonomy and right not to know is respected. Decision aids can also be implemented as a tool for patients to use on their own, or to facilitate discussions between patients and health care professionals.
To the best of our knowledge, no tools are currently available to facilitate decision-making among research participants considering whether or not to take up germline genomic research findings. To address this gap, a decision aid was developed to provide decision support for research participants, based on the preference-sensitive nature of the decision in question and the fact that a decision aid could be easily integrated into existing research procedures. Thus, the aims of this study were to (i) develop a decision aid consistent with the International Patient Decision Aids Standards (IPDAS) to assist individuals notified of clinically actionable germline genomic research findings to make informed and valueconsistent choices regarding attendance at a familial cancer clinic for genetic counseling; and (ii) to pilot test the decision aid among individuals who have previously taken up results to determine its acceptability prior to implementation.
Methods

Decision Aid Development
Framework
The International Patient Decision Aids Standards (IPDAS) were used to guide the development of the decision aid. The IPDAS guidelines provide a framework for the development and evaluation of decision aids and state that decision aids should, as a minimum, (i) make explicit decision to be made, (ii) provide evidence-based information regarding the health issue, including the options available and their benefits and harms, and (iii) enable the reader to appreciate the preferencesensitive nature of the decision and clarify their own values and preferences in relation to the decision (Coulter et al. 2013; Durand et al. 2015; Joseph-Williams et al. 2014 ). Additional quality criteria for decision aids include the quality of the evidence (including synthesis, providing sources, and production date), balanced and unbiased information presentation, and transparency regarding funding sources. An explicit values clarification exercise or question prompts for use in interactions with health care professionals may also be included to enhance the user experience (Joseph-Williams et al. 2014) . The development process used in this study, based on the IPDAS model, is described below.
Scoping
The scope of the decision aid was to increase informed choice regarding the option of genetic counseling for clinically actionable research findings pertaining to cancer risk. The target audience was genomic research participants who were notified of clinically actionable research findings, specifically a pathogenic germline variant in a known cancer predisposition gene. This group includes both (i) index cases in whom research testing has identified a pathogenic variant and who are eligible for genetic counseling and confirmatory clinical testing through an accredited laboratory; and (ii) at-risk relatives whose genetic status is unknown and who are eligible for predictive testing after appropriate genetic counseling. An online search was conducted to identify any existing resources meeting this need; however, no resources that were immediately appropriate or readily adaptable for this setting were identified.
Expert Steering Committee
The IPDAS guidelines recommend the steering committee include both clinicians and patients. Thus, the steering committee assembled for the decision aid development consisted of two consumers, both enrolled in a population-based research study of individuals diagnosed with sarcoma and their at-risk relatives; two cancer genetic counselors, one with experience in returning research results to participants enrolled in genomic studies; two psychosocial health researchers with expertise in the fields of health literacy and psychosocial aspects of hereditary cancer; and two clinical researchers with expertise in the design and implementation of genomic research studies, including one medical oncologist.
Design
A paper-based tool was chosen as research participants are currently notified of clinically actionable findings by letter and it was important for the tool to fit in with current notification processes (McBride et al. 2016; Wakefield et al. 2013) . The content of the decision aid (outlined in Table 1 ) focused on the uptake of genetic counseling for research results relating to cancer risk in a general sense, given the details of the research findings (i.e., the specific gene and associated cancer risks) are not provided to the participants in the notification letter. Key issues for individuals referred to genetic counseling were identified using the expertise of the steering committee and the published literature, including a systematic review of the literature regarding genetic counseling uptake, the results of which are described elsewhere (Willis et al. 2017) . The steering committee then developed content to address these key issues, as described in the Supplementary Table. The final stage in the design process was professional graphic design, which was undertaken after the decision aid content was finalized based on the results of the pilot test.
Prototype Development
The prototype development was an iterative process, with the content and structure of the resource informed by the IPDAS guidelines. In order to ensure the decision aid was accessible to a broad audience, the steering committee aimed for a maximum readability score of eighth grade, as recommended by IPDAS (McCaffery et al. 2013 ). However, readability scores only take into account average word and sentence length in measuring text difficulty. Therefore, principles of systemic functional linguistics were also applied in the content development process (Clerehan et al. 2005 ). These principles describe how contextual and structural aspects of the text, such as headings and subheadings, logical information presentation, use of plain language, and visual cues can improve people's understanding.
Research also suggests that the inclusion of pictures and diagrams can increase visual appeal and engagement with written health information and may also increase recall and text comprehension (Houts et al. 2006 ). In addition, it is recommended that both frequency statements and diagrams are used to convey numerical risks to aid understanding and cater to varying reader preferences, with 100-person diagrams as an effective and acceptable visual method for conveying and personalizing risk information (Hawley et al. 2008; Smit et al. 2016) . Based on this, numerical risks in the decision aid were provided in both text and diagram format and simple illustrations relating to the themes of the text were included throughout the decision aid (Fig. 1) . The text was also supplemented by quotes from participants who had received clinically actionable findings from other research studies to illustrate the range of responses to receiving genetic information McBride et al. 2016) . A values clarification exercise was included at the end of the booklet to aid participants in their decision-making (Fig. 2) . 
Independent Clinician Review
The decision aid was reviewed by three independent clinicians with expertise in hereditary cancer, who were not involved in the decision aid content development, but had been involved in recruiting individuals to cancer genomic studies and/or disclosing clinically actionable research findings. The decision aid content was revised based on the clinician feedback, with only minor changes made relating to content accuracy and appropriateness of language.
Pilot Test
Participants
The sample for the pilot test was recruited through two existing research cohorts based at a large metropolitan cancer treatment center in Victoria, Australia: (i) The International Sarcoma Kindred Study (ISKS), a clinic-based cohort of individuals diagnosed with sarcoma and their at-risk relatives ; and (ii) The Kathleen Cuningham Foundation Consortium for Research into Familial Aspects of Breast Cancer (kConFab), a research cohort of families with a strong family history of breast/ovarian cancer recruited via 32 familial cancer clinics throughout Australia and New Zealand (Thorne et al. 2011) . The study was reviewed and approved by the Human Research Ethics Committee at the Peter MacCallum Cancer Centre. In addition to being enrolled in the ISKS or kConFab, participants had to satisfy the following criteria: (i) received notification of clinically actionable research findings from the ISKS or kConFab and had undergone confirmatory clinical genetic testing at a familial cancer clinic; (ii) aged 18 and over and able to give informed consent; (iii) able to read and understand information materials written in English and complete a self-report questionnaire in English; and (iv) not suffering cognitive or psychiatric impairment.
Procedures
Seventy individuals meeting the eligibility criteria were sent a letter of invitation, participant information sheet, consent form, reply slip, and a reply-paid envelope. Individuals who did not respond to the invitation within 2 weeks received a telephone call to confirm their participation. Individuals agreeing to participate were posted a copy of the prototype decision aid, a questionnaire, and reply-paid envelope and were requested to read the decision aid, provide their feedback in the questionnaire, and return the questionnaire by post.
Data were collected by self-administered questionnaire, which included measures adapted from a previous study (Wakefield et al. 2007 ). Questions addressed the main components of acceptability: booklet length and amount of information, balance of presentation, and utility for decision-making. Data were collected on perceived improvements in understanding for key concepts addressed in the decision aid to indicate whether the key messages in the booklet were adequately communicated and guide any content revision that may be required. Emotional reactions to reading the decision aid and satisfaction with the presentation of the decision aid were also assessed. Open text responses were used in addition to quantitative items, in order to capture more detailed feedback on any aspects of the decision aid requiring revision. Participant age, occupation, and level of education were also assessed in the questionnaire. Additional demographic data, including gender, mutation status, and personal and family history of cancer, were accessed directly through the parent study with participants' consent.
Data Analysis
A descriptive analysis of the data was undertaken using Statistical Program for the Social Science 23.0 (SPSS, Chicago, IL). Open text responses were examined to identify themes that might indicate necessary changes to the decision aid prior to implementation.
Results
Demographic Characteristics of Participants
Letters of invitation were sent to 70 individuals, six enrolled in the ISKS and 64 enrolled in kConFab. Signed consent forms were received from 27 individuals, and 19 individuals returned completed questionnaires, resulting in an overall response rate of 27%. All individuals consenting to participate were from the kConFab cohort and the demographic characteristics of the participants are presented in Table 2 . Fifty-eight percent of participants had completed a non-school qualification, consistent with the national average (Australian Bureau of Statistics 2015).
Acceptability
Overall, participants rated the decision aid highly in terms of its acceptability. The amount of time taken to read the decision aid varied from 5 to 10 min (1/19), 10 to 20 min (11/19), 20 to 30 min (6/19), to more than 30 min (1/19). Eighteen of the 19 participants indicated the amount of information provided, length, and level of direction of the decision aid were about right. None of the participants found anything in the decision aid confusing, and 18 participants indicated that the decision aid explained the available options clearly or very clearly. The decision aid met (13/19), exceeded (4/19), or greatly exceeded (2/19) the expectations of all participants, and all 19 participants were either satisfied (8/19) or very satisfied (11/19) with the information provided. All 19 participants stated that the decision aid was useful and that they would recommend the decision aid to other people who were considering accessing genetic information regarding cancer risk.
Perceived Knowledge
Participants were asked whether they thought the decision aid Bwould have improved their understanding^of a range of topics related to the decision described in the decision aid (i.e., uptake of genetic counseling for research results). The majority of participants indicated that the decision aid would have increased their understanding Ba lot^or Bquite a bitâ cross most topics, with the greatest improvements in understanding regarding the availability of genetic information (Table 3) . However, the perceived improvement in understanding for the pros and cons of not accessing genetic information did not score as highly, with one participant indicating that the decision aid would Bnot at all^have improved their understanding and two only Bsomewhat.P
resentation
The decision aid rated highly across most aspects of presentation (Fig. 3) . Visual appeal received the lowest ratings, justifying the earlier decision to engage professional graphic design services. When asked about the order in which the topics were presented, 18 out of 19 participants indicated that they liked the order of the topics, while one was unsure. One participant indicated that there were parts of the decision aid that could be left out, stating that they felt the values clarification exercise was unnecessary. Two participants indicated that there were parts of the decision aid that should have been explained in more detail, with one desiring more information about the types of cancer the genetic test related to and another wanting more emphasis on the negative consequences of not accessing the genetic information.
Participants were asked how useful the visual features in the decision aid were in helping to understand the information in the decision aid, with space provided for open text responses. The 100-person diagram demonstrating the proportion of cancer and hereditary cancer in the general population rated very highly, with participants finding it Bvery useful( 5/19) or Buseful^(14/19). The response to the illustrations was mixed: eight of the 19 participants found them Bvery useful,^nine Bsomewhat useful,^and two Bnot at all usefulî n helping to understand the information. When asked what they thought of the illustrations, one participant indicated that they thought the illustrations were Bchildish^; however, the remaining participants had either neutral or positive attitudes, generally indicating the illustrations softened and supported the information. None of the participants suggested a preferred alternative to the illustrations used.
Quotes from individuals who had received clinically actionable research findings from other research studies were included throughout the decision aid to support the text. Participants found these quotes either Bvery useful^(12/19) or Bsomewhat useful^(7/19) in helping them to understand the text and information. Participants also found the quotes either Bvery useful^(11/19) or Bsomewhat useful^(8/19) in helping them relate to the information in the decision aid.
Emotional Reactions to the Decision Aid
Participants were asked how much they had thought about the information provided in the decision aid since having read it, with five of the 19 participants indicating they had thought about the information Ba lot,^three Bquite a bit,^eight Bsomewhat,^and three Ba little.^Few participants reported feeling Bworried or concerned^or Bsad or upset^after reading the decision aid, with those who did reporting only low levels (Fig. 4) . Five participants responded when asked what, if anything, had made them worried or upset. Participants indicated that concern regarding the impact of the information on their relatives and/or the decision aid bringing back memories of learning their mutation status or family members who had passed away had elicited these feelings.
In contrast, all participants reported some level of reassurance from reading the decision aid (Fig. 4) . Eight participants who indicated what, if anything, had reassured them reported reassurance from having easy to understand information, having their options clearly presented and acknowledged as valid, knowing further Fig. 3 Pilot test participants' ratings of the presentation and usefulness of the decision aid support was available if required, and knowing that others had also found the process challenging.
Open Text Responses
Additional open text responses were included in the questionnaire to gather more general feedback on the decision aid. When asked BWhat did you like most about the booklet?^, nine participants stated that they liked that it was Beasy to read and understand.^Eight participants commented positively on the quality or appropriateness of the information and three participants liked that the decision aid was supportive and provided links to further support and information. When asked BWhat did you like least?^, the majority of participants (n = 11) stated Bnothing^or did not respond. Two participants stated they least liked the values clarification exercise, two participants suggested the illustrations were Bcartoony^or Bchildish,^and another two participants stated they least liked the comments regarding the downsides of accessing genetic information. Eighteen participants responded when asked BWhat do you think are the main ideas that the booklet is trying to get across.^The most common response was choice and the fact that there are options available to them (n = 10), followed by information provision (n = 7) and the availability of support (n = 6). Two participants indicated that the main idea was to encourage people to undergo genetic testing.
Participants were asked whether there Bwas anything you would want to know that wasn't covered in the booklet?^. The majority of participants indicated that no further information was required, or did not respond (n = 14). Of those who wanted further information, two wanted more information regarding the cancer risks implicated by the genetic information or the options for cancer risk management following a positive result, one wanted detailed information regarding Bthe science behind the testing,^and one commented that the familial cancer clinic they attended was not listed in the decision aid.
Revising the Decision Aid Following Pilot Testing
The decision aid content was finalized based on the results of the pilot test. The decision aid length, amount of information, topics, and structure were maintained, with minor changes made to clarify some of the messages based on participants' answers to the perceived knowledge questions. The decision aid then underwent professional graphic design, with close communication between the designers and steering committee to ensure the final document complied with health literacy best practice with regard to layout and readability. Key changes made during the graphic design process included the cover design, addition of color, placement of text and illustrations, and changing the 100-person diagram to a 20-person diagram to reduce page crowding. The final decision aid was a 32 A5 page document with a raw readability level of between eighth and ninth grade measured using the Flesch-Kincaid readability score. However, this may have been artificially inflated by repeated use of the term Bgenetic information,^which appears throughout the decision aid to describe the research findings and contains two three syllable words. Removal of these words reduced the score to between sixth and seventh grade.
Discussion
This article describes the development and pilot testing of a decision aid for individuals considering genetic counseling following notification of clinically actionable germline genomic research results. Decision aids have been produced for a number of genetic testing settings, screening options, and riskreducing surgeries in the hereditary cancer setting. However, to our knowledge, this is the first decision aid aimed at supporting genomic research participants through decisionmaking regarding uptake of germline genomic research results for cancer risk.
The need for additional decision support at the time of notification is evidenced by studies that have identified low perceived relevance and even misunderstanding of notification and referral letters among individuals eligible for genetic testing (McBride et al. 2016; Vadaparampil et al. 2009; Wakefield et al. 2011a ). In the research setting, this misunderstanding is not entirely surprising, given there is often a substantial time delay between study enrolment and the return of clinically actionable findings to research participants. Other research studies have tried to overcome this by following up research participants by phone to confirm receipt of the letter and address any questions they may have. There was no significant increase in genetic testing uptake observed using this strategy, though rates of informed decision-making were not measured and may have increased (Wakefield et al. 2013) . The complexity and resources required to notify research participants of clinically actionable findings are also likely to increase in the genomic setting, as greater numbers of participants receive results from research. Supplementing the notification process by providing easy-to-read, written information at the time of notification has the benefit of removing the requirement to make contact with a familial cancer clinic to access further information, potentially increasing access to information for research participants and decreasing the time burden associated with notification for researchers and clinicians. A simple educational intervention could have been argued for in this setting, given there are well-recognized benefits to individuals from participating in genetic counseling (McAllister and Dearing 2015; Nelson et al. 2014) . However, the decision in question of whether an individual should attend genetic counseling to receive research results regarding cancer risk prompts consideration of the medical ethical principle of respect for individual autonomy with regard to genetic information and the individual's Bright not to know^ (Beauchamp and Childress 2009; Gillon 1994) . Given individual autonomy to opt out of genetic counseling and testing for a range of reasons is still respected in other settings, particularly given timing and personal circumstances can be highly relevant to uptake of genetic information (McBride et al. 2016 ), a decision to attend genetic counseling for research results would likely still be considered preference-sensitive. As such, a decision aid provides added benefit over educational materials only, given a decision aid includes information about the decision, alongside the benefits and downsides of available options, which respects individual autonomy and supports decision-making that is consistent with personal values (Beauchamp and Childress 2009; Stacey et al. 2017) .
Developing a decision aid in the genomic research setting was not without its challenges, particularly given the gene in question is not known at the time of notification and thus no cancer-specific information regarding risks and risk management options could be provided. One of the most significant challenges was the fact that the content, which focused on the decision to access genetic counseling, did not lend itself to the numerical comparison of risks and benefits traditionally seen in decision aids. This necessitated a deviation from the traditional decision aid content and presentation in favor of a more descriptive presentation of the risks and benefits of genetic counseling, as well as the emotional and familial concerns experienced by those referred to genetic counseling. However, care was taken to maintain the key structural elements of a decision aid, such as balance of information presentation, opportunities to clarify values, and directions to follow through with the preferred option in order to maximize consistency with the IPDAS guidelines and ensure the resource provides appropriate and effective decision support (Joseph-Williams et al. 2014) .
Despite the challenges faced in the development process, the decision aid was rated as highly acceptable by pilot test participants. The amount of information, length, and presentation all received positive feedback, as did the information clarity, with none of the participants indicating that the content was confusing. This feedback was reinforced by the positive comments provided by participants in the open text responses, with a number of participants describing the decision aid as informative and easy to read and understand. This was an important finding, given that health literacy, commonly defined as the Bcapacity to acquire, understand and use information in ways which promote and maintain good health^ (Institute of Medicine 2004) , is suboptimal in the community. There is also evidence that low health literacy contributes to poor health (Berkman et al. 2011) . The fact that the pilot test sample was representative of the general Australian population with regard to education level also suggests that the information provided and the readability level of the decision aid is appropriate for the target audience.
Provision of clear and appropriate information is an important part of increasing patient participation in health care decisions by improving patient knowledge and enabling preparation for appointments (McPherson et al. 2001) . The benefits of meaningful patient participation in health care decisions are also well established, including improvements to the safety, quality, and cost-effectiveness of health care and increases in patient satisfaction (Greene and Hibbard 2012; Weingart et al. 2011) . The importance of information provision at the time of referral has also been demonstrated in the hereditary cancer setting, with patients reporting a lack of information at referral leading to uninformed decision-making, anxiety in the lead-up to the genetic counseling appointment, and lower satisfaction with the genetic counseling process (Metcalfe et al. 2007 ).
To facilitate patient engagement and informed decisionmaking, appropriate information would not only be accessible and easy to understand, but also respect patient autonomy and present a balanced view of the available options. The decision aid format adds value to the provision of information by providing balanced information and increasing decision-making that is consistent with personal values and preferences (Stacey et al. 2017) . In this context, presenting both accessing and not accessing genetic information as options and side-by-side display of the benefits and limitations of each option was used to balance the provision of information (Abhyankar et al. 2013) . The findings that the information delivery and balance were appropriate and that participants would recommend the decision aid for use in decision-making are reassuring. However, two participants perceived the decision aid to be encouraging genetic testing and participants reported greater improvements in knowledge regarding the pros and cons of accessing the results compared to not accessing the results. This may have been due to the pilot test sample having positive attitudes to genetic information, given they had already made a decision to take up research results. These positive attitudes may also explain why some participants indicated that the values clarification exercise was unnecessary, and the perceived utility of the exercise may be greater among those who are actively making decisions regarding uptake of genetic information.
Emotional reactions to genetic information are common in genetic counseling, with evidence that individuals may decline genetic services based on anticipated distress for themselves or their relatives (Bleiker et al. 2005; Kasparian et al. 2009 ). This is despite studies showing either no effect, or only short-term increases in anxiety and/or distress among individuals undergoing genetic counseling or testing (Braithwaite et al. 2004; Heshka et al. 2008; Meiser 2005) . Thus, the possibility of the decision aid causing distress for readers was of concern, particularly given the decision aid was designed to be read at home with no immediate support from a health care professional, although access to a genetic counselor was available by telephone. While pilot test participants did report some concern (mostly for relatives) after reading the decision aid, only low levels of worry or distress were reported. In addition, all participants reported some level of reassurance from reading the decision aid. These findings are consistent with the findings of similar studies measuring the acceptability of decision aids for genetic testing decisions (Wakefield et al. 2007 (Wakefield et al. , 2011b .
Study Limitations
Despite the encouraging findings from this pilot test, it should be acknowledged that these findings may not reflect the views of research participants notified of germline genomic information more broadly. Firstly, none of the ISKS-enrolled individuals consented to participate in the study; thus, all of the participants were recruited through a research cohort of families with a strong family history of breast/ovarian cancer. Also, few men were recruited, limiting the extent to which these results may be extrapolated to men.
The response rate of 27% was also slightly lower than other studies using similar recruitment methods and data regarding non-responders was not available for comparison (Ratnayake et al. 2011; Wakefield et al. 2007) . The low response rates in both cohorts may be explained by the time delay between notification of clinically actionable research findings from the parent study and the invitation to review the decision aid, with the study perhaps perceived as less relevant to invitees. Pilot test participants had also already received the results of research genomic testing, so the feedback obtained is hypothetical in nature in that pilot test participants were not actually making decisions at the time of providing feedback. Pilot test participants were also likely to be positively disposed towards receiving health information, given that they had previously made the decision to access their own research results.
Practice Implications
The decision aid has been implemented prospectively in the result notification process for research participants considering whether to take up genomic testing results for cancer risk in the Australian arm of the International Sarcoma Kindred Study. Given the generic nature of the information provided in the decision aid, it is also available for adaptation and implementation in the notification process of similar genomic research studies. The decision aid can be viewed online at http://www. psychosocialresearchgroupunsw.org/decision-aids.html (BMaking a decision about accessing genetic information for cancer risk^).
Future Directions
While the results of this pilot are encouraging, the next step is for the decision aid to be tested prospectively among individuals making actual decisions regarding uptake of clinically actionable genomic research findings. The acceptability of the decision aid is being prospectively assessed among ISKS individuals receiving the decision aid at the time of decisionmaking. However, given this is a small cohort, the effectiveness of the decision aid may be better measured through implementation and assessment in a larger cohort. Continued research into new methods of notifying research participants of their results is recommended, particularly given the increase in access to online health information and the flexibility of online formats, which may enable better integration of decision support in the notification process. In the event that participant and researcher preferences shift to online notification and information provision, adaptation of successful decision support interventions, or the development of new interventions, for online access will be needed.
Conclusion
There is an information and decision support gap for individuals considering genetic counseling after being notified of germline genomic research results. This study shows that, despite the challenges of creating resources in the genomic setting, developing a highly acceptable decision support tool for genomic research participants is possible. High satisfaction and endorsement of the decision aid by pilot test participants suggest that the decision aid will be similarly acceptable when provided prospectively to individuals making actual decisions about genetic counseling for genomic research results.
